Dr. Ruth K.M. Pfau Civil Hospital, Karachi Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2020
NCT04723524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dr. Ruth K.M. Pfau Civil Hospital, Karachi

Active Ingredients

Drugs in Phase 4 Trials (2)

bupivacaine (Exparel) (1 trial)

dexmedetomidine (precedex) (2 trials)

Drugs in Phase 2 Trials (1)

jinhua qinggan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3